Sign in
Create a Profile
Modeling Stress-precipitated Smoking Behavior for Medication Development
Diseases and Conditions Researched
Smoking
What is the purpose of this trial?
The purpose of this study is to examine whether guanfacine or carvedilol will attenuate the ability of stress to precipitate smoking lapse behavior in treatment seeking and non-treatment seeking daily smokers. Participants seeking treatment for smoking will participate in a smoking cessation attempt after the laboratory sessions. Also looking at gender differences.
Participation Guidelines
Gender: Both
Click here for detailed participation information for this trial.
| Sponsors: | National Institute on Drug Abuse (NIDA); Office of Research on Women's Health (ORWH); Yale University |
|---|---|
| Dates: | October 14, 2008 |
| Last Updated: | July 31, 2012 |
| Study HIC#: | 0808004163 |
| Clinicaltrials.gov ID: | NCT00773357 |
How will my information be used?
For more information about this trial, contact:
Meaghan Lavery
203-737-2738
Principal Investigator
McKee, Sherry
Psychiatry
How will my information be used?
When you express interest in a specific study, the information from your profile will be sent to the doctor conducting that study. If you're eligible to participate, you may be contacted by a nurse or study coordinator.
If you select a health category rather than a specific study, doctors who have active studies in that area may contact you to ask if you would like to participate.
In both cases, you will be contacted by the preferred method (email or phone) that you specified in your profile.
